EU Anti-Poverty Strategy Report adopted: Civil society welcomes Parliament’s vote but report still leaves many behind

On Thursday, 12 February 2026, the European Parliament adopted its position on the upcoming EU Anti-Poverty Strategy of the European Commission.

On 10 February, the European Parliament adopted legislation that will have immediate and dangerous consequences for trans people seeking asylum in the European Union.

We are pleased to announce the publication of the third edition of Human Rights and Gender Identity: Best Practice Catalogue, a new e-publication documenting concrete and effective approaches to advancing equality for trans people across Europe and beyond.

This report provides an overview of TGEU’s membership engagement work throughout 2025, building on the ongoing commitment to strengthen trans-led organising, leadership, and collaboration across Europe and Central Asia.

TGEU’s new report, Systemic harm, human cost, shows the scale and reality  of anti-trans violence in Eastern Europe and Central Asia (EECA) at a time when political and social conditions for trans people have deteriorated significantly.

On 11th of December, over 150 organisations published a joint statement to strongly urge the leaders and institutions of the European Union to take actions toward the elimination of conversion practices.

Learn about trans refugees’ resistance and community building in our new publication

TGEU is looking for an Interm Executive Director starting in February/March 2026. This is a full-time position, 40 hours/week.

The forthcoming EU Anti-Poverty Strategy must be comprehensive, ambitious, adequately funded, and anchored in meaningful targets towards the eradication of poverty. The Coalition on the EU Anti-Poverty Strategy urges Members of the European Parliament (MEPs) to uphold this level of ambition during the plenary vote scheduled for January 2026.

Between 2024 and 2025, the Court of Justice of the European Union (CJEU), the EU's highest Court, issued four important judgments on the rights of trans people in the EU. This toolkit empowers trans activists to understand why these rulings matter and helps them use them in their important work.

The recently announced PATHWAYS clinical trial protocol on puberty blockers (also known as puberty suppressing hormones) for young trans people in the UK represents a deeply troubling escalation in the erosion of young trans people’s rights and mental and physical health. 

We are appalled and alarmed by the legislative initiatives underway…